#1#2Livent Safe Harbor Statement Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Certain statements in this presentation are forward- looking statements. In some cases, you can identify these statements by forward-looking words such as "may," "might," "will," "should," "expects," "plans," "anticipates," "believes," "estimates," "predicts," "potential" or "continue," the negative of these terms and other comparable terminology. These forward-looking statements, which are subject to risks, uncertainties and assumptions about us, may include projections of our future financial performance, our anticipated growth strategies and anticipated trends in our business. These statements are only predictions based our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements, including a decline in the growth in demand for electric vehicles; adverse global economic conditions; the success of our research and development efforts; volatility in the price for performance lithium compounds; risks relating to our planned production expansion and related capital expenditures; the potential development and adoption of battery technologies that do not rely on performance lithium compounds as an input; risks inherent in international operations and sales, including political, financial and operational risks specific to Argentina and other countries where we have active operations, including China; customer concentration and the possible loss of, or significant reduction in orders from, large customers; failure to satisfy customer quality standards; fluctuations in the price of energy and certain raw materials; failure to achieve the expected benefits of our separation from FMC as well as the other factors described under the caption entitled "Risk Factors" in our prospectus dated October 10, 2018 filed with the Securities and Exchange Commission on October 12, 2018. Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements. We are under no duty to update any of these forward-looking statements after the date of this presentation to conform our prior statements to actual results or revised expectations. Non-GAAP Financial Terms These slides contain certain non-GAAP financial terms. We have provided on our website at www.livent.com reconciliations of non-GAAP terms to the most directly comparable GAAP term, including adjusted earnings per share, Adjusted EBITDA and adjusted cash from operations. Although we provide forecasts for adjusted earnings per share, Adjusted EBITDA and adjusted cash from operations, we are not able to forecast the most directly comparable measures calculated and presented in accordance with GAAP. Certain elements of the composition of the GAAP amounts are not predictable, making it impractical for us to forecast. Such elements include, but are not limited to restructuring, transaction related charges and related cash activity. As a result, no GAAP outlook is provided. 2#3#4Livent Q4 Adj. EBITDA (1) Bridge $48.2 FMC Segment EBITDA Q4 2017 ($4.9) $43.3 Carve out Livent Adj. Accounting EBITDA (1) Adj. Q4 2017 Note: Amounts in millions of USD. (1) Denotes non-GAAP financial term. $1.8 Volume $0.3 Price / Mix + 5% ($2.2) Cost & Other $2.4 F/X $45.6 Livent Adj. (1) EBITDA Q4 2018 4#5Livent Full Year 2018 Adj. EBITDA (1) Bridge $141.9 FMC Segment EBITDA FY 2017 ($15.8) Note: Amounts in millions of USD. (1) Denotes non-GAAP financial term. $126.1 Carve out Livent Adj. Accounting EBITDA (1) Adj. FY 2017 $45.7 Volume $27.3 Price / Mix + 45% ($16.7) Cost & Other $0.5 F/X $182.9 Livent Adj. EBITDA FY 2018 (1) 01 5#6#7#8#9#10#11#12#13#14